These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 11057947)
1. Genomic events in the adenoma to carcinoma sequence. Terdiman JP Semin Gastrointest Dis; 2000 Oct; 11(4):194-206. PubMed ID: 11057947 [TBL] [Abstract][Full Text] [Related]
2. Somatic evolution of cancer cells. Boland CR; Goel A Semin Cancer Biol; 2005 Dec; 15(6):436-50. PubMed ID: 16055343 [TBL] [Abstract][Full Text] [Related]
3. [Predictive molecular diagnosis and preventive surgical treatment of hereditary colorectal carcinoma: a new field of interest for surgical research]. Hahn M; Kruppa C; Pistorius S; Schackert HK Zentralbl Chir; 1999; 124(4):278-85. PubMed ID: 10355081 [TBL] [Abstract][Full Text] [Related]
6. Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Jones S; Lambert S; Williams GT; Best JM; Sampson JR; Cheadle JP Br J Cancer; 2004 Apr; 90(8):1591-3. PubMed ID: 15083190 [TBL] [Abstract][Full Text] [Related]
7. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157 [TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma. Kim JC; Koo KH; Roh SA; Cho YK; Kim HC; Yu CS; Kim HJ; Kim JS; Cho MK Int J Colorectal Dis; 2003 May; 18(3):203-9. PubMed ID: 12673484 [TBL] [Abstract][Full Text] [Related]
9. [Molecular-genetic leads for prevention and treatment of colorectal carcinoma]. Offerhaus GJ; Baas IO Ned Tijdschr Geneeskd; 1994 Mar; 138(11):561-4. PubMed ID: 8139721 [No Abstract] [Full Text] [Related]
17. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome]. Lakatos PL; Lakatos L Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174 [TBL] [Abstract][Full Text] [Related]
18. Can we identify the high-risk patients to be screened? A genetic approach. Gammon A; Kohlmann W; Burt R Digestion; 2007; 76(1):7-19. PubMed ID: 17947814 [TBL] [Abstract][Full Text] [Related]
19. [Sporadic and hereditary colorectal cancer. Pathogenetically different with different therapeutic indications]. Weitz J; Knaebel HP; Büchler MW Chirurg; 2003 Aug; 74(8):717-25. PubMed ID: 12928792 [TBL] [Abstract][Full Text] [Related]
20. The molecular biology of colorectal cancer development and the associated genetic events. Navaratnam RM; Chowaniec J; Winslet MC Ann R Coll Surg Engl; 1999 Sep; 81(5):312-9. PubMed ID: 10645173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]